These findings are relevant for three other human diseases associated with TREX1 mutations, Aicardi–Gouitères syndrome (AGS), systemic lupus erythematosus (SLE), and familial chilblain lupus (FCL) 3, 13, 14, 20. This evidence concerns the gene TREX1 and systemic lupus erythematosus.